Vascular-targeted genomic and genetic strategies for acute chest syndrome

Active Project Grant Awarded Last action

Award ID
R01HL111656
Recipient
Awarding agency
Obligated
$12,534,664

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date 95% complete
Originally
Funding
  • $11,946,259.00 Federal
  • $588,405.00 Non-federal
Place of performance
Baltimore, MD 21201, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $687,436 $0
Amendment $0 $0
Amendment $0 $0
Amendment $365,258 $0
Amendment $365,258 $0
Amendment $365,258 $0
Amendment -$365,260 $0
Amendment -$365,260 $0
Amendment -$365,260 $0
Amendment Vascular targeting genomic & genetic strategies for acute chest syndrome $709,465 $0
Amendment Vascular-targeting genomic and genetic strategies for acute chest syndrome $0 $0
Amendment $0 $0
Amendment Vascular targeting genomic & genetic strategies for acute chest syndrome $0 $0
Amendment $0 $0
Amendment Vascular-targeting genomic and genetic strategies for acute chest syndrome $0 $0
Amendment Vascular targeting genomic & genetic strategies for acute chest syndrome $0 $0
Amendment $0 $0
Amendment Vascular-targeting genomic and genetic strategies for acute chest syndrome $0 $0
Amendment $695,276 $0
Amendment Vascular targeting genomic & genetic strategies for acute chest syndrome $695,276 $0
Amendment $695,276 $0
Amendment Vascular-targeting genomic and genetic strategies for acute chest syndrome $695,276 $0
Amendment $753,340 $0
Amendment Vascular targeting genomic & genetic strategies for acute chest syndrome $753,340 $0
Amendment $588,405 $0
Amendment $588,405 $0
Amendment $588,405 $588,405
Amendment $588,405 $0
Amendment Vascular-targeting genomic and genetic strategies for acute chest syndrome $595,016 $0
Amendment $0 $0
Amendment $838 $0
Amendment $269,520 $0
Amendment $624,920 $0
Amendment -$270,358 $0
Amendment $513,649 $0
Amendment $513,649 $0
Amendment $521,655 $0
Amendment $42,366 $0
Amendment $476,641 $0
Original award $620,064 $0
Show all 40

Subawards

Subrecipient Amount Awarded
The Morehouse School Of Medicine, Inc. Vascular Targeting Genomic & Genetic Strategies for Acute Chest Syndrome. $21,497
University Of Illinois We will use our expertise in translational research to utilize a range of genomic approaches to participate in the investigation of the modifiers and biomarkers… $148,643
Versiti Blood Health, Inc. Intravital lung microscopy in live sickle cell disease (SCD) and chimeric SCD mice will be used in Aim 2 to study the role of RASA3 in acute chest syndrome… $81,564
The Morehouse School Of Medicine, Inc. Drs. Kittles and Lewis will work closely with Dr. Machado to conduct and supervise the analysis of genetic association studies of candidate genes associated… $108,968

Quick answers

Who received award R01HL111656?

R01HL111656 was awarded to University Of Maryland, Baltimore by National Heart Lung and Blood Institute (National Institutes of Health) on February 5, 2013.

How much is award R01HL111656 worth?

$12,534,664 has been obligated on R01HL111656: $11,946,259 in federal funding and $588,405 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login